ICD-10 Z79.85
Billable / SpecificLong-term (current) use of injectable non-insulin antidiabetic drugs
About ICD-10-CM Z79.85
ICD-10-CM code Z79.85 represents Long-term (current) use of injectable non-insulin antidiabetic drugs. This is a billable/specific code in the Factors Influencing Health Status chapter (block Z79). The 2026 edition of ICD-10-CM Z79.85 became effective on October 1, 2025.
Type 2 Excludes
Not included here, the excluded code is not part of Z79.85, but a patient may have both conditions at the same time. Both codes may be coded together when applicable.
- long term (current) use of insulin (Z79.4)
- long term (current) use of oral hypoglycemic drugs (Z79.84)
Medicare LCD Coverage for Z79.85
Local Coverage Determinations (LCDs) from CMS MACs that list Z79.85 as a covered diagnosis.
Showing top 10 of 187 total . Click a CPT for full coverage scope.
Commercial Payer Coverage
Coverage policies from major commercial payers referencing Z79.85.
5 Medicare
CPT Codes Commonly Billed with Z79.85
Procedures frequently paired with this diagnosis based on PayerReady's Dx↔Px linkage data.
- 0003M CMS LCD: Billing and Coding: MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis CMS LCD
- 0468U CMS LCD: Billing and Coding: MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis CMS LCD
- 0166U CMS LCD: Billing and Coding: MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis CMS LCD
- 81517 CMS LCD: Billing and Coding: MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis CMS LCD
- 0344U CMS LCD: Billing and Coding: MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis CMS LCD
Codes Adjacent To Z79.85
Other codes in section Z77-Z99 (Persons with potential health hazards related to family and personal history and certain conditions influencing health status).
ICD-10 Z79.85, Billing FAQ
Is ICD-10 code Z79.85 billable? +
Yes, Z79.85 is a billable ICD-10-CM code that can appear as a primary or secondary diagnosis on claims.
What codes are Type 2 Excludes for Z79.85? +
Type 2 Excludes (may be coded together when both conditions exist): long term (current) use of insulin (Z79.4); long term (current) use of oral hypoglycemic drugs (Z79.84)
What CPT codes are commonly billed with Z79.85? +
Procedures frequently paired with Z79.85 include: 0003M, 0468U, 0166U, 81517, 0344U.
Get the full PayerReady toolkit
Free access to CPT/ICD-10 lookup, denial appeals, fee comparator, and claim auditing with credentialing enrollment.
Start free →Run this code through our claim audit tool
Check NCCI bundling, MUE limits, and modifier logic before submission.
Try the auditor →Did this page help?
Quick signal so we know what to improve.
If you want a code reference page that doesn't exist yet, email coding@payerready.com.
Tell us what's missing or wrong: coding@payerready.com. We respond within 5 business days.
Reviewed by the PayerReady Medical Coding Team
Verified against the CMS 2026 code set on July 16, 2026.
Powered by 11K CPT · 98K ICD-10 · 860K MPFS rates · 4.5M NCCI edits · 9.5M NPIs. Our data methodology · About our coding team